| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US314916 | 1989-02-24 | ||
| US31491694A | 1994-09-28 | 1994-09-28 | |
| PCT/US1995/011316WO1996009838A1 (en) | 1994-09-28 | 1995-09-08 | METHOD OF TREATING MACULAR DEGENERATION USING TGF-$g(b) |
| Publication Number | Publication Date |
|---|---|
| AU3584895Atrue AU3584895A (en) | 1996-04-19 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU35848/95AAbandonedAU3584895A (en) | 1994-09-28 | 1995-09-08 | Method of treating macular degeneration using tgf-beta |
| Country | Link |
|---|---|
| AU (1) | AU3584895A (en) |
| WO (1) | WO1996009838A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688765A (en)* | 1992-04-21 | 1997-11-18 | The Schepens Eye Research Institute, Inc. | Ocular therapy in Sjogren's syndrome using topically applied androgensor TGF-β |
| US6309374B1 (en) | 1998-08-03 | 2001-10-30 | Insite Vision Incorporated | Injection apparatus and method of using same |
| US6378526B1 (en)* | 1998-08-03 | 2002-04-30 | Insite Vision, Incorporated | Methods of ophthalmic administration |
| EP1252895A4 (en)* | 2000-01-31 | 2003-04-16 | Santen Pharmaceutical Co Ltd | Remedies for ophthalmic diseases |
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
| JP5996544B2 (en) | 2010-10-15 | 2016-09-21 | クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ | Eye access device |
| EP3721872B1 (en) | 2012-11-08 | 2025-01-22 | Clearside Biomedical Inc. | Methods for the treatment of ocular disease in human subjects |
| EP2991706B1 (en) | 2013-05-03 | 2021-06-23 | Clearside Biomedical, Inc. | Apparatus and methods for ocular injection |
| US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
| RU2540504C1 (en)* | 2013-12-26 | 2015-02-10 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Method for prediction of risk of late retinal detachment in children with cicatrical retinopathy of prematurity |
| CA2952958A1 (en) | 2014-06-20 | 2015-12-23 | Clearside Biomedical, Inc. | Variable diameter cannula and methods for controlling insertion depth for medicament delivery |
| EP3413851B1 (en) | 2016-02-10 | 2023-09-27 | Clearside Biomedical, Inc. | Packaging |
| CA3062845A1 (en) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
| CN110177527B (en) | 2016-08-12 | 2022-02-01 | 科尼尔赛德生物医学公司 | Device and method for adjusting insertion depth of needle for medicament delivery |
| US12090294B2 (en) | 2017-05-02 | 2024-09-17 | Georgia Tech Research Corporation | Targeted drug delivery methods using a microneedle |
| Publication number | Publication date |
|---|---|
| WO1996009838A1 (en) | 1996-04-04 |
| Publication | Publication Date | Title |
|---|---|---|
| IL117793A0 (en) | Method for the treatment of macular degeneration | |
| AU5387796A (en) | Method and compositions for treating impotence | |
| AU6694596A (en) | Method and composition for treating asthma | |
| AU2593900A (en) | Composition and method for treating glaucoma | |
| AU7373096A (en) | Method for treating contaminated soils with ozone | |
| AU4668193A (en) | Method of treating ophthalmic disorders using tgf-beta | |
| AU4348597A (en) | Composition and method for repairing neurological tissue | |
| AU2464195A (en) | Method of performing laser therapy | |
| AU3584895A (en) | Method of treating macular degeneration using tgf-beta | |
| AU1935395A (en) | Method for treating conditions of the eye using polypeptides | |
| AUPN271295A0 (en) | Method of treatment | |
| ZA944323B (en) | Method for treating hypoxia-associated ocular complications | |
| AU3950297A (en) | Method of sterilising material for implantation | |
| AU7592991A (en) | Composition and method for controlling cholesterol | |
| AU1714697A (en) | Method and composition for the treatment of osteoarthritis | |
| AU3369595A (en) | Methods for inhibiting bone prosthesis degeneration | |
| AU8003694A (en) | Method for treating coffee aromas | |
| AU1587495A (en) | Process for the treatment of contaminated land | |
| IL109762A0 (en) | Method for treating hypoxia-associated ocular complications | |
| AU6165898A (en) | Method and apparatus for the treatment of strabismus | |
| AU4027097A (en) | Method of treatment | |
| AU2393500A (en) | Method for preventing and treating the degeneration of neurons | |
| AU6345699A (en) | Use of gndf for treating retinal degeneration | |
| AU7340694A (en) | Treatment of age-related macular degeneration | |
| AU3779595A (en) | Method of treating turf |